These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 21747382)

  • 21. Obtaining, challenging and enforcing pharmaceutical patents under the America Invents Act.
    Genieser LH; McCann CE
    Pharm Pat Anal; 2012 Sep; 1(4):415-26. PubMed ID: 24236880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic engineering patents. Contest in prospect over interferon rights.
    Beardsley T
    Nature; 1985 Mar 21-27; 314(6008):207. PubMed ID: 3982495
    [No Abstract]   [Full Text] [Related]  

  • 23. Intellectual property protection: strategies for antibody inventions.
    Storz U
    MAbs; 2011; 3(3):310-7. PubMed ID: 21494091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacia pilots patent share for HIV drug.
    Nat Rev Drug Discov; 2003 Apr; 2(4):254. PubMed ID: 12680360
    [No Abstract]   [Full Text] [Related]  

  • 25. Design-around biotechnology patents: an analysis of US Federal Circuit decisions shows the possibility of designing around biotechnology patents.
    Wang SJ
    Hum Vaccin; 2011 Jan; 7(1):125-8. PubMed ID: 21263222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibacterial agents: patent highlights January to June 2002.
    Phillips OA; Matowe WC
    Curr Opin Investig Drugs; 2002 Dec; 3(12):1701-11. PubMed ID: 12528302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patent protection. Canadian drug firms boost R&D spending.
    Spurgeon D
    Nature; 1992 Feb; 355(6362):666. PubMed ID: 1741046
    [No Abstract]   [Full Text] [Related]  

  • 28. The extraterritoriality of US patents on the pharmaceutical industry.
    Park H
    Pharm Pat Anal; 2014 Sep; 3(5):491-8. PubMed ID: 25374318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [From the molecule to the drug: innovation or distribution].
    Ménard HA
    Union Med Can; 1993; 122(1):4. PubMed ID: 8465475
    [No Abstract]   [Full Text] [Related]  

  • 30. Patenting genes: a fast and furious primer.
    Askland A
    Int J Appl Philos; 2003; 17(2):267-75. PubMed ID: 15462042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Strategy and core technologies for the secondary development of Chinese patent medicine].
    Zhagn BL; Fan XH; Liu Y; Qu HB; Zhang JH; Chegn YY
    Zhongguo Zhong Yao Za Zhi; 2013 Nov; 38(22):3797-800. PubMed ID: 24558853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patents and the research exemption.
    Resnik DB
    Science; 2003 Feb; 299(5608):821-2. PubMed ID: 12574602
    [No Abstract]   [Full Text] [Related]  

  • 33. Reach-through claims for drug target patents: Rx for pharmaceutical policy.
    Bohrer RA
    Nat Biotechnol; 2008 Jan; 26(1):55-6. PubMed ID: 18183015
    [No Abstract]   [Full Text] [Related]  

  • 34. The evolving role of biomarker patents in personalized medicine.
    Kesselheim AS; Shiu N
    Clin Pharmacol Ther; 2014 Feb; 95(2):127-9. PubMed ID: 24448456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth spurt. As patents expire, focus is on high-priced drugs.
    Lee J
    Mod Healthc; 2013 Jan; 43(4):7, 16. PubMed ID: 23488109
    [No Abstract]   [Full Text] [Related]  

  • 36. AIDS group takes aim at pharmaceutical firm's patents, prices.
    AIDS Policy Law; 2002 Jul; 17(13):4. PubMed ID: 12162289
    [No Abstract]   [Full Text] [Related]  

  • 37. Patents: a threat to innovation?
    Manocaran M
    Science; 2010 Jan; 327(5961):31-2; author reply 32. PubMed ID: 20044557
    [No Abstract]   [Full Text] [Related]  

  • 38. Some empirical evidence on post-patent barriers to entry in the Canadian pharmaceutical industry.
    McRae JJ; Tapon F
    J Health Econ; 1985 Mar; 4(1):43-61. PubMed ID: 10271145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Obviousness, hindsight and perspective: the impact of KSR v. Teleflex on biotech and pharmaceutical patents.
    Teitelbaum R; Cohen M
    Nat Biotechnol; 2007 Oct; 25(10):1105-6. PubMed ID: 17921990
    [No Abstract]   [Full Text] [Related]  

  • 40. Nurses making a difference: the process of technology transfer.
    Johnson VY; Walsh EG
    J Neurosci Nurs; 2005 Oct; 37(5):289-92. PubMed ID: 16379136
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.